Hematology and Oncology of Northeast Georgia
Athens, Georgia, United States
Hematologist in Athens, Georgia
3320 Old Jefferson Rd, Athens, GA 30607
About Hematology and Oncology of Northeast Georgia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
2
Eastern Cooperative Oncology Group
1
Clinical Trials at Hematology and Oncology of Northeast Georgia
During the past decade, Hematology and Oncology of Northeast Georgia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Bladder Cancer
2004-03-01
2009-04-01
Completed
42
Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
2004-04-01
2009-05-01
Completed
46
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology and Oncology of Northeast Georgia"
#1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hematology and Oncology of Northeast Georgia
According to Clinical.Site data, the most researched conditions in "Hematology and Oncology of Northeast Georgia" are
"Bladder Cancer" (2 trials), "Kidney Cancer" (1 trials), "Transitional Cell Cancer of the Renal Pelvis and Ureter" (1 trials) and "Urethral Cancer" (1 trials). Many other conditions were trialed in "Hematology and Oncology of Northeast Georgia" in a lesser frequency.
Clinical Trials Intervention Types at Hematology and Oncology of Northeast Georgia
Most popular intervention types in "Hematology and Oncology of Northeast Georgia" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "bevacizumab" (1 trials), "cisplatin" (1 trials), "doxorubicin hydrochloride" (1 trials) and "filgrastim" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology and Oncology of Northeast Georgia
The vast majority of trials in "Hematology and Oncology of Northeast Georgia" are
3 trials for "All" genders.
Clinical Trials Status at Hematology and Oncology of Northeast Georgia
Currently, there are NaN active trials in "Hematology and Oncology of Northeast Georgia".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hematology and Oncology of Northeast Georgia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hematology and Oncology of Northeast Georgia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".